DUBLIN--(BUSINESS WIRE)--The "Global Inhalation Anesthetics Market - Growth, Trends and Forecast 2017 - 2022" report has been added to Research and Markets' offering.
The market for inhalation anesthetic agents is increasing continuously due to the boost in its use because of a few factors. The increase in geriatric population causes a major fraction of population to be more susceptible to chronic diseases like cardiovascular, respiratory, cancer, neurological and other health ailments such as gastro, orthopedic and spinal problems.
Other factors affecting the growth positively include elevating number of emergency services and increasing demand for lesser hospitalization days hence causing the healthcare providers to use such agents more frequently. One more reason of boost in inhalation anesthetic agents use is the improved accessibility to healthcare services for people across the world. This has led to more number of surgeries that are being conducted per year and hence more amounts of IAs being used.
The major anesthetic agents that are currently being used have generic competitors and hence market shares offset to some extent. Also, expiration of a few patents during recent years has caused the figures to suppress. The current market faces some key challenges for entry, say regulatory guidelines, and thus discourages new players.
Companies Mentioned:
- Baxter
- Abbvie
- Piramal Healthcare
- Lunan Pharmaceuticals
- Others
Key Topics Covered:
1. Introduction
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview and Industry Trends
6. Drivers, Restraints, Opportunities and Challenges Analysis
7. Global Inhalation Anaesthetics Market Segmentation
8. Global Inhalation Anaesthetics market by Geography - Regional shares and forecast
9. Competitive Landscape
10. Company Profiles
11. Analyst Outlook for Investment Opportunities
12. Future Outlook of the Market
For more information about this report visit https://www.researchandmarkets.com/research/967rl5/global_inhalation
